PI3K? inhibitor TGX221 selectively inhibits renal cell carcinoma cells with both VHL and SETD2 mutations and links multiple pathways.
Scientific reports 2015 5 9465.
Feng Chenchen, Sun Yang, Ding Guanxiong, Wu Zhong, Jiang Haowen, Wang Lujia, Ding Qiang, Wen H
Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Jun 19 (12): 3259-67.
Hakimi A Ari, Ostrovnaya Irina, Reva Boris, Schultz Nikolaus, Chen Ying-Bei, Gonen Mithat, Liu Han, Takeda Shugaku, Voss Martin H, Tickoo Satish K, Reuter Victor E, Russo Paul, Cheng Emily H, Sander Chris, Motzer Robert J, Hsieh James J,